Better Tests- Improving Diagnostic Accuracy and Prognostication in Interstitial Lung Diseases (Better Tests)
Patients with interstitial lung diseases (ILD) suffer significant delays in obtaining a diagnosis, and objective evidence of support for immunosuppressive therapies, due to weaknesses in the diagnostic tests available in ILD clinics.
This project will assess several non-invasive assessments, focusing on blood and breath based sampling, to identify candidate tests that may translate through to routine clinical use. The tests being assessed will be initially employed in Pigeon Fanciers, a group recognised to be at high risk of developing ILD compared to age matched controls, due to their regular exposure to a known cause of ILD. Candidate tests will also be assessed for change over time in this group. Tests which show promise will then be utilised in patients with ILD diagnoses, including those with severe respiratory failure, to assess their acceptability to patients and their ability to provide useful prognostic information, to allow powering of future definitive clinical trials.
Visão geral do estudo
Status
Condições
Descrição detalhada
Pigeon Fanciers attending a recruitment event at one of the large national meetings for the sport will undergo assessments after completion of informed consent. The basic assessments include collection of height, weight and lung function (e.g. spirometry). In addition we will collect basic information about current health, past medical history and current pigeon keeping habits (number kept, time spent with birds etc). Participants will then have a blood sample taken for collection of antibody level against Pigeons, and for storage for subsequent processing of relevant candidate objective tests. Participants will also perform an additional breathing test to allow collection of exhaled air, which will be analysed on site or via subsequent testing (dependent on test required). Results will be linked to symptoms on exposure to their pigeons and any subsequent diagnoses obtained.
Subsequent follow up of the Pigeon Fancier cohort, again via the participants attendance at large national meetings, will allow repeat of the candidate tests, enabling determination of natural variation and the effect of change in exposure or development of new medical conditions. We will also examine the dynamic change in candidate tests following natural exposures to causes of ILD, by performing the tests with a subset of Pigeon Fanciers before, during and after exposure to their birds.
Patients attending Interstitial Lung Disease clinics in NHS Tayside, and when admitted with their Interstitial Lung Disease, will be offered the opportunity to perform the non-invasive assessments available to Pigeon Fanciers, with their results being linked to subsequent clinical outcomes (progression of disease, response to treatment and time to death).
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Mark Spears, PhD FRCP
- Número de telefone: +44 1738 473861
- E-mail: mspears001@dundee.ac.uk
Locais de estudo
-
-
-
Blackpool, Reino Unido, FY1 1HU
- Recrutamento
- Winter Gardens
-
Contato:
- Mark Spears, PhD FRCP
- Número de telefone: 44 1253 629600
- E-mail: mspears001@dundee.ac.uk
-
Investigador principal:
- Mark Spears, PhD FRCP
-
Dundee, Reino Unido, DD21UB
- Recrutamento
- Ninewells Hospital
-
Investigador principal:
- Mark Spears, PhD FRCP
-
Contato:
- Mark Spears, PhD FRCP
- Número de telefone: 44 1382 660111
- E-mail: mspears001@dundee.ac.uk
-
Perth, Reino Unido, PH1 1NX
- Recrutamento
- Perth Royal Infirmary
-
Investigador principal:
- Mark Spears, PhD FRCP
-
Contato:
- Mar Spears, PhD FRCP
- Número de telefone: 44 1738 473861
- E-mail: mspears001@dundee.ac.uk
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
To participate subjects will either have to be active Pigeon Fanciers, or will be either attending ILD clinics for management of their interstitial lung disease or will present acutely to hospital services with severe respiratory failure due to ILD.
Exclusion Criteria:
Unable to provide informed consent
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Pigeon Fanciers
Active Pigeon Fanciers
|
|
Clinic patients with ILD
Patients with established Interstitial Lung Disease attending clinic
|
|
Hospital patients with ILD
Patients with established Interstitial Lung Disease admitted due to their condition
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Prediction of subsequent clinical outcomes
Prazo: 5 years
|
The utilised tests will be examined for their ability to accurately predict the subsequent diagnostic label for ILD and clinical behaviour
|
5 years
|
|
Acceptability to participants
Prazo: 5 years
|
The tests employed will be assessed for their ease of performance and acceptability from a participant perspective
|
5 years
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Mark Spears, PhD FRCP, NHS Tayside and University of Dundee
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 3-067-24
- Charity (Número de outro subsídio/financiamento: British Pigeon Fanciers Medical Research Charity)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .